Table 5

Disability, balance, walking, upper limb, and global impression of mobility (assessor)5-150. Scores before and after treatment (mean (SD)): effect sizes by treatment: n=40 patients

ScaleTreatment
NoneHospitalHome
Pre Post Pre Post Pre Post
Rivermead mobility index (0–15)10.0 (3.7) 9.1 (3.9)10.0 (3.6)10.5 (3.5)9.6 (3.2)10.6 (2.9)
Effect size Estimate 95% CI p Value
Hospital-none 1.4 0.62 to 2.14<0.001
Home-none 1.5 0.73 to 2.26<0.001
Home-hospital 0.1−0.65 to 0.87 0.77
Pre Post Pre Post Pre Post
Balance time (s)17.7 (13.7)15.0 (13.8)18.1 (13.3)19.9 (13.2)15.0 (13.4)19.7 (13.2)
Effect size Estimate 95% CI p Value
Hospital-none 4.82 1.57 to 8.07 0.004
Home-none 5.49 2.19 to 8.80 0.001
Home-hospital 0.68−2.64 to 3.99 0.69
Pre Post Pre Post Pre Post
Walk A (s)143 (117)148 (129)151 (125)138 (108)145 (115)138 (110)
Effect size Estimate 95% CI p Value
Hospital-none−14−23 to −5 0.003
Home-none−14−23 to −6 0.002
Home-hospital0−9 to 8 0.94
Pre Post Pre Post Pre Post
Nine hole peg (s)194 (67)207 (85)199 (86)190 (69)201 (76)194 (70)
Effect size Estimate 95% CI p Value
Hospital-none−18−32 to −4 0.014
Home-none−13−27 to 1 0.076
Home-hospital5−9 to 19 0.48
Post FU Post FU Post FU
Assessor global5-151 mobility change scale (0–100: 50=no change)42 (11)46 (11)62 (17)44 (11)65 (17)44 (14)
Diff post-treatment score Estimate 95% CI p Value
Hospital-none19.814.0 to 25.7<0.001
Home-none22.416.6 to 28.3<0.001
Home-hospital 2.6−3.2 to 8.4 0.38
  • 5-150 The results for all other scales used in the study are available from the authors in similar format.

  • 5-151 For this scale “Post” refers to the assessment immediately after treatment period: “FU” (follow up) refers to that undertaken 6–7 weeks later during which no treatment was given.